Biogen shares jumped by the most since the company’s Alzheimer’s disease treatment was approved in the U.S., after a Korean …
Your email address will not be published. Required fields are marked *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.
test account :
